Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan

被引：0
|
作者：
Fumitaka Suzuki
Tetsuya Hosaka
Yoshiyuki Suzuki
Hitomi Sezaki
Norio Akuta
Shunichiro Fujiyama
Yusuke Kawamura
Masahiro Kobayashi
Satoshi Saitoh
Yasuji Arase
Kenji Ikeda
Mariko Kobayashi
Rie Mineta
Yukiko Suzuki
Hiromitsu Kumada
机构：
[1] Toranomon Hospital,Department of Hepatology
[2] Okinaka Memorial Institute for Medical Research,Research Institute for Hepatology
[3] Toranomon Branch Hospital,undefined
来源：
Journal of Gastroenterology | 2019年 / 54卷
关键词：
Hepatitis B virus; Entecavir; HBsAg seroclearance; Resistance; Viral breakthrough;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：182 / 193
页数：11
相关论文
共 50 条
  • [11] Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
    Elia Moreno-Cubero
    Robert T Sánchez del Arco
    Julia Pe?a-Asensio
    Eduardo Sanz de Villalobos
    Joaquín Míquel
    Juan Ramón Larrubia
    World Journal of Gastroenterology, 2018, 24 (17) : 1825 - 1838
  • [12] Persistence profile to nucleos(t)ide analogue treatment for patients with chronic hepatitis B
    Borrego Izquierdo, Yolanda
    Gomez Fernandez, Encarnacion
    Monje Agudo, Patricia
    Jimenez Galan, Rocio
    Almeida-Gonzalez, Carmen V.
    Ferrit Martin, Monica
    Morillo Verdugo, Ramon
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2016, 23 (05) : 278 - 282
  • [13] Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Cho, Yuri
    Lee, Yun Bin
    Yoo, Jeong-Ju
    Lee, Minjong
    Lee, Dong Hyeon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    PLOS ONE, 2015, 10 (06):
  • [14] Comparison of the efficacy of entecavir and tenofovir in nucleos(t)ide analogue-experienced chronic hepatitis B patients
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Cho, Yuri
    Lee, Yun Bin
    Yoo, Jeong-Ju
    Lee, Minjong
    Lee, Donghyeon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2015, 62 : 1210A - 1210A
  • [15] Outcome of chronic hepatitis B patients who discontinued nucleos(t)ide analogue therapy
    Yapali, Suna
    Oberhelman, Kelly
    Lok, Anna S.
    HEPATOLOGY, 2014, 60 : 1114A - 1115A
  • [16] Long-term Nucleos(t)ide Analogue Consolidation Therapy Reduces Risk of Relapse in Chronic Hepatitis B
    Chi, Heng
    Hansen, Bettina E.
    Arends, Pauline
    Abu-Amara, Mahmoud
    Yim, Colina
    Feld, Jordan J.
    de Knegt, Robert J.
    Wong, David K.
    Janssen, Harry L.
    HEPATOLOGY, 2014, 60 : 1090A - 1091A
  • [17] Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients
    He, D.
    Guo, S.
    Zhu, P.
    Tao, S.
    Li, M.
    Huang, H.
    Wang, J.
    Wang, Y.
    Ding, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O687 - O693
  • [18] Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
    Chotiyaputta, Watcharasak
    Peterson, Carolyn
    Ditah, Fausta A.
    Goodwin, Diane
    Lok, Anna S. F.
    JOURNAL OF HEPATOLOGY, 2011, 54 (01) : 12 - 18
  • [19] Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapy
    Hsu, Wei-Fan
    Chen, Chuen-Fei
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Chen, Sheng-Hung
    Chen, Ching-Hsiang
    Wang, Hung-Wei
    Huang, Guan-Tarn
    Peng, Cheng-Yuan
    LIVER INTERNATIONAL, 2018, 38 (04) : 627 - 635
  • [20] Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B
    Farnik, Harald
    Lange, Christian Markus
    Hofmann, Wolf Peter
    Berger, Annemarie
    Allwinn, Regina
    Welker, Martin-Walter
    Trojan, Joerg
    Sarrazin, Christoph
    Herrmann, Eva
    Zeuzem, Stefan
    Kronenberger, Bernd
    JOURNAL OF CLINICAL VIROLOGY, 2011, 52 (03) : 204 - 209
12345